ReviewBiodegradation2025
Hybrid membrane technology with renewably derived biological and photocatalytic systems for wastewater treatment.
Review in Biodegradation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Numerous physical, chemical, and biological treatment strategies for removing pollutants from wastewater have been studied for several decades. Nevertheless, these methodologies possess some constraints. Since the early 2000s, membrane-based hybrid technology has been increasingly recognized and adopted due to advancements in manufacturing and casting methods, as well as membrane modification techniques. Membrane-based treatment technology, coupled with other semi-renewable treatment technologies such as advanced oxidation processes (photocatalysis), bioreactors, and hybrid membrane bioreactors, is adopted as an substitute to conventional wastewater treatment due to its ease of operation and superior performance. In this study, a thorough examination of these attractive hybrid technologies is conducted. Additionally, this study also assorted the stand-alone methods and techniques associated with membrane reactors, photocatalytic membrane reactors (PCMRs), and membrane bioreactors (MBRs). MBRs and PCMRs deliver effective and sustainable wastewater treatment by integrating biological processes or photocatalysis with membrane filtration, yielding high-quality effluents suitable for reuse. The benefits of these renewably derived integrations include their compact design, diminished sludge generation, and capacity for water recycling. However, fouling remains significant challenges, primarily resulting from foulant adherence, pore clogging, creation of a cake layer, and the temporal alogn with spatial changes in the structure of foulants are identified as key processes that contribute to fouling in PCMRS. The interaction of bacteria, membrane surfaces, and the secretion of extracellular polymeric substances are responsible for biofouling in MBRs. Incorporating AOP (photocatalysts) into MBR membranes presents a novel approach to mitigate fouling. The integration of catalysis and membrane filtration systems can stretch membrane lifespan, eliminate membrane surface contamination, and decompose organic pollutants simultaneously, thereby enhancing wastewater treatment efficiency. This study offers a thorough examination of contemporary research regarding membrane modification utilizing photocatalysts in MBR systems, emphasizing the prevailing challenges and future opportunities in this domain. Notwithstanding these possible benefits, studies aimed at enhancing MBR membrane effectiveness via photocatalysis are limited. To preserve the sustainability of this technology, it is imperative to consider key factors, including reactor configuration, kinetics, fouling processes, economic viability, and scaling challenges.
Indexed as
Identifiers
40788420What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.